CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling
Bai-Quan Qiu, Peng-Fei Zhang, Dian Xiong, Jian-Jun Xu, Xiang Long, Shu-Qiang Zhu, Xu-Dong Ye, Yin Wu, Xu Pei, Xue-Mei Zhang, Yong-Bing Wu
Journal:JOURNAL OF CELLULAR PHYSIOLOGY
IF:3.92
DOI:10.1002/jcp.27783
PMID:30565694
Published:2018-11-22
research field:肿瘤学分子生物学癌症研究
Abstract
The dysregulation of circular RNA (circRNA) expression is involved in the progression of several cancers, including non-small cell lung cancer (NSCLC). However, the role and underlying molecular mechanisms of circRNA FGFR3 (circFGFR3) in NSCLC progression remains unknown. Here, we used quantitative real-time polymerase chain reaction to validate that circFGFR3 expression was higher in NSCLC tissues than in the paratumor tissues. Furthermore, our study indicated that the forced circFGFR3 expression promoted NSCLC cell invasion and proliferation. Mechanistically, we found that circFGFR3 promoted NSCLC cell invasion and proliferation via competitively combining with miR-22-3p to facilitate the galectin-1 (Gal-1), p-AKT, and p-ERK1/2 expressions. Clinically, we revealed that the high circFGFR3 expression correlates with the poor clinical outcomes in patients with NSCLC. Together, these data provide mechanistic insights into the circFGFR3-mediated regulation of both the AKT and ERK1/2 signaling pathways by sponging miR-22-3p and increasing Gal-1 expression.
本文使用的Yeasen产品


